Chest - Pneumonia
Pneumonia seen in these MPR images of this 49-year-old man with shortness of breath and BMI 25.4
Courtesy South Coast Radiology Qld, Australia
View Scan Parameters| Scan Mode | Ultra Helical |
| Collimation | 0.5 mm × 80 |
| kVp | 120 |
| mAs | SUREExposure |
| Rotation Time | 0.35 s |
| Scan Range | 409 mm |
| Dose Reduction | AiCE |
| CTDIvol | 4.5 mGy |
| DLP | 204.4 mGy·cm |
| Effective Dose | 2.9 mSv |
| k-factor | 0.014 (AAPM Report 96) |
Chest – Calcified Nodule
82-year-old man, follow up chest CT demonstrates a calcified lung nodule in the right lung
Courtesy South Coast Radiology Qld, Australia
View Scan Parameters| Scan Mode | Ultra Helical |
| Collimation | 0.5 mm × 80 |
| kVp | 120 |
| mAs | SUREExposure |
| Rotation Time | 0.35 s |
| Scan Range | 364.5 mm |
| Dose Reduction | AiCE |
| CTDIvol | 5.2 mGy |
| DLP | 214 mGy·cm |
| Effective Dose | 3.0 mSv |
| k-factor | 0.014 (AAPM Report 96) |
Low dose chest with SilverBeam
SilverBeam in combination with AiCE Deep Learning Reconstruction provides excellent image quality at dose levels more comparable to a chest x-ray.
In this patient the DLP was only 24 mGy.cm with an effective dose of 0.3 mSv.
Courtesy
Medic Medical Center, HCMC Vietnam
| Scan Mode | SilverBeam Ultra-Helical |
| Collimation | 0.5 mm x 80 |
| kVp | 120 |
| mAs | SUREExposure |
| Rotation Time | 0.5 s |
| Scan Range | 241 mm |
| Dose Reduction | AiCE |
| CTDIvol | 0.70 mGy |
| DLP | 24.70 mGy-cm |
| Effective Dose | 0.34 mSv |
| k-factor | 0.014 (AAPM Report 96) |
Pulmonary CTA - Iodine Mapping SCT
Color iodine maps quickly and definitively show areas of hypoperfusion to enhance your diagnosis.
Hyperperfused areas are commonly associated with pulmonary pathology as demonstrated in this case of a pulmonary embolism.
Courtesy
Royal Bournemouth Hospital, Bournemouth, UK
| Scan Mode | Ultra-Helical |
| Collimation | 0.5 mm × 80 |
| kVp | 120 |
| mAs | SURE Exposure |
| Rotation Time | 0.35 s |
| Scan Range | 300 mm |
| Dose Reduction | AiCE |
| CTDIvol | 1.6, 2.0 mGy |
| DLP | 126.9 mGy-cm |
| Effective Dose | 1.78 mSv |
| k-factor | 0.014 (AAPM Report 96) |
Rib Fractures
51-year-old woman with prior fall. Global Illumination rendering provides excellent depiction of multiple rib fractures
Courtesy South Coast Radiology Qld, Australia
View Scan Parameters| Scan Mode | Ultra Helical |
| Collimation | 0.5 mm × 80 |
| kVp | 120 |
| mAs | SUREExposure |
| Rotation Time | 0.35 s |
| Scan Range | 376 mm |
| Dose Reduction | AiCE |
| CTDIvol | 2.9 mGy |
| DLP | 123.5 mGy·cm |
| Effective Dose | 1.7 mSv |
| k-factor | 0.014 (AAPM Report 96) |
Portal Abdomen
Low noise, excellent image quality in this portal phase abdomen scan
Courtesy
Royal Bournemouth Hospital, Bournemouth, UK
| Scan Mode | Ultra-Helical |
| Collimation | 0.5 mm × 80 |
| kVp | 120 |
| mAs | SURE Exposure |
| Rotation Time | 0.5 s |
| Scan Range | 449 mm |
| Dose Reduction | AiCE |
| CTDIvol | 4.3 mGy |
| DLP | 213.9 mGy-cm |
| Effective Dose | 3.2 mSv |
| k-factor | 0.015 (AAPM Report 96) |
Multi Phase Abdomen – Iodine Mapping SCT
Color iodine maps can be provided with every multiphase abdomen protocol to further enhance your diagnostic confidence.
Iodine mapping can help to visualize and differentiate hypervascular lesions such as hepatocellular carcinoma (HCC) as seen in this case.
Here a hyper-vascularized arterial lesion can be easily visualized in both the gray scale image and color iodine maps. The lesion also demonstrates a “washout” pattern in the venous and delayed phase consistent with imaging findings associated with HCC.
Courtesy
Medic Medical Center, HCMC Vietnam
| Scan Mode | Ultra-Helical |
| Collimation | 0.5 mm × 80 |
| kVp | 120 |
| mAs | SURE Exposure |
| Rotation Time | 0.5 s |
| Scan Range | 456, 456, 456, 200 mm |
| Dose Reduction | AiCE |
| CTDIvol | 4.8, 4.8, 4.8, 4.8 mGy |
| DLP | 833 mGy-cm |
| Effective Dose | 12.49 mSv |
| k-factor | 0.015 (AAPM Report 96) |
Multi Phase Abdomen – Iodine Mapping SCT
Iodine mapping can help to visualize and differentiate hypervascular lesions that may exhibit similar enhancements in the arterial phase.
Here a hyper-vascularized arterial lesion can be easily visualized in both the gray scale image and color iodine maps.
The iodine maps unequivocally show the lesion still retains some contrast material in the venous and delayed, but the enhancement is less intense compared to the arterial phase.
Courtesy
Medic Medical Center, HCMC Vietnam
| Scan Mode | Ultra-Helical |
| Collimation | 0.5 mm x 80 |
| kVp | 120 |
| mAs | SUREExposure |
| Rotation Time | 0.5 s |
| Scan Range | 288, 280, 452, 333 mm |
| Dose Reduction | AiCE |
| CTDIvol | 4.8, 4.8, 4.8, 4.8 mGy |
| DLP | 876 mGy-cm |
| Effective Dose | 13.14 mSv |
| k-factor | 0.015 (AAPM Report 96) |
Aorta CTA + SEMAR
SEMAR removes artifacts from the stent graft in this CTA of the abdominal aorta
Courtesy Hakujyuji Hospital, Japan
View Scan Parameters| Scan Mode | Ultra Helical |
| Collimation | 0.5 mm × 80 |
| kVp | 120 |
| mAs | SUREExposure |
| Rotation Time | 0.5 s |
| Dose Reduction | AiCE |
| CTDIvol | 7.9 mGy |
| DLP | 550.3 mGy·cm |
| Effective Dose | 8 mSv |
| k-factor | 0.0145 (AAPM Report 96) |
Lumbar Spine
High quality soft tissue and bone reconstructions with AiCE
Courtesy South Coast Radiology Qld, Australia
View Scan Parameters| Scan Mode | Ultra Helical |
| Collimation | 0.5 mm × 80 |
| kVp | 120 |
| mAs | SUREExposure |
| Rotation Time | 0.5 s |
| Scan Range | 321 mm |
| Dose Reduction | AiCE |
| CTDIvol | 14 mGy |
| DLP | 507.4 mGy·cm |
| Effective Dose | 7.6 mSv |
| k-factor | 0.015 (AAPM Report 96) |
Due to medical device regulatory reasons, not all products/service displayed on this Canon Medical Systems Malaysia webpage are available in all countries, regions or markets. Future availability of the products/service cannot also be guaranteed. Please contact your local Canon Medical Systems representative for further details.
